ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
다우존스 지수
40,003.59
0.34%
Bitcoin
66,813.18
-0.40%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. AbCellera Biologics Inc (ABCL)

  7. AbCellera Biologics Inc (ABCL) 뉴스

ABCL

AbCellera Biologics (ABCL)

AbCellera Biologics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ABCL
일자시간출처헤드라인심볼기업
2024/05/0805:47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABCLAbCellera Biologics Inc
2024/05/0805:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
2024/05/0805:05Business WireAbCellera Reports Q1 2024 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
2024/05/0122:00Business WireAbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech CompaniesNASDAQ:ABCLAbCellera Biologics Inc
2024/04/0901:05Business WireAbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024NASDAQ:ABCLAbCellera Biologics Inc
2024/04/0405:05Business WireAbCellera to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:ABCLAbCellera Biologics Inc
2024/03/2005:05Business WireAbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024NASDAQ:ABCLAbCellera Biologics Inc
2024/03/1122:00Business WireAbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological ConditionsNASDAQ:ABCLAbCellera Biologics Inc
2024/03/0606:30Business WireAbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024NASDAQ:ABCLAbCellera Biologics Inc
2024/02/2804:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
2024/02/2406:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
2024/02/2406:30Business WireAbCellera Announces Resignation of Board MemberNASDAQ:ABCLAbCellera Biologics Inc
2024/02/2310:15Business WireAbCellera to Present at Upcoming Investor Conferences in MarchNASDAQ:ABCLAbCellera Biologics Inc
2024/02/2106:49Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ABCLAbCellera Biologics Inc
2024/02/2106:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
2024/02/2106:05Business WireAbCellera Reports Full Year 2023 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
2024/01/2406:05Business WireAbCellera to Report Full Year 2023 Financial Results on February 20, 2024NASDAQ:ABCLAbCellera Biologics Inc
2024/01/1708:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
2024/01/1708:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
2024/01/1708:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
2024/01/1708:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
2023/12/2106:05Business WireAbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024NASDAQ:ABCLAbCellera Biologics Inc
2023/12/2008:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
2023/11/2907:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
2023/11/2806:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
2023/11/1706:05Business WireAbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023NASDAQ:ABCLAbCellera Biologics Inc
2023/11/0905:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
2023/11/0905:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
2023/11/0905:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
2023/11/0401:05Business WireAbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023NASDAQ:ABCLAbCellera Biologics Inc
 검색 관련기사 보기:NASDAQ:ABCL

최근 히스토리

FX
USDCDF
US Dollar vs CDF
BIT
F17373
Vontobel Financial Produ...
BIT
S28246
Societe Generale Effekten
BIT
UI306B
Unicredit Bank
BIT
F05983
Vontobel Financial Produ...
HUOB
RSRUSDT
Reserve Rights
COIN
SVDEUR
BIT
F12448
Zucchero
COIN
DGBETH
DigiByte
LSE
AO34
Gov.hk.26 (s)
BIT
P21QS7
NLBNPIT21QS7 20991231 1....
LSE
0IND
First Trust Dow Jones In...
HUOB
STAKEBTC
xDai STAKE
AMEX
IWR
iShares Russell Mid Cap
TSX
CALL
Evolve US Banks Enchance...
EU
XS1935139995
ABN AMRO Bank NV 0.875% ...
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유